Advertisement
Horizon Discovery
Horizon Discovery

Bacterial Cocktail Treats Infection

Mice fed a mix of six strains of bacteria were able to fight a C. difficile infection that causes deadly diarrhea and is resistant to most types of treatment.

By | October 29, 2012

C. difficile cultures
Wikimedia, CDC, Holdeman
Clostridium difficile
is a common disease in hospitals and nursing homes and causes some 14,000 deaths each year in the United States. The disease can be treated with antibiotics, but the bacteria produce spores that resist common disinfection techniques, resulting in a high rate of re-infection. (See “Wrestling with Recurrent Infections,” The Scientist, May 2011, for an overview of C. difficile infections and treatment options.) Now, researchers from the Wellcome Trust Sanger Institute have isolated a combination of six other bacteria species that successfully fight C. difficile infections in mice, potentially paving the way toward standardized therapy, according to a report in PLOS Pathology last week (October 25).

The only successful treatment to date has been fecal therapy, which involves the transfer of fecal material from a healthy individual directly into the intestines of an infected patient.  However, the treatment is controversial because it risks introducing pathogenic strains, in addition to the healthful ones. Instead, the Sanger Institute researchers took fecal matter that successfully cured mice and cultured the bacteria from it. They isolated 18 types of bacteria and determined that a mixture of six of those was sufficient to successfully treat the disease. 

“Fecal transplantation is viewed as an alternative treatment, but it is not widely used because of the risk of introducing harmful pathogens as well as general patient aversion,” lead author Gordon Dougan from the Wellcome Trust Sanger Institute, in the United Kingdom told Genetic Engineering and Biotechnology News. “This model encapsulates some of the features of fecal therapy and acts as a basis to develop standardized treatment mixture.”

(Hat tip to ScienceNOW)

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: AlanB

AlanB

Posts: 16

November 21, 2012

Fecal transplantation is not an "alternative treatment" and it doesn't introduce any greater risks than the process of colonisation that occurs from birth, nor does it represent a greater pathogen risk than the person already suffers from prior to the treatment. You can tell that by looking at the overall robustness and health of donors and following up on those donated to. Any treatment contains adverse risks and conceptually, there is nothing special in this regard that should have it catagorised as a fringe or 'alternative' therapy. If it works, it works. Trimming the number of strains down and culturing them seperately is STILL fecal transplantation, and whilst it may help here in C Difficile infection, it may fail to protect against many other dissorders. I certainly also hope that there is no patenting of these strains, they are part of a natural defense largely knocked out by antibiotics in the first place. 

Avatar of: lab792003

lab792003

Posts: 1

December 21, 2012

hi

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
RayBiotech
RayBiotech

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Cisbio
Cisbio
Advertisement